T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Williams Companies
WMB
$90.1B
| $51.3M | 0.01% |
1,142,303
+17,820
| +2% | +$911K |
|
827
Navient
NAVI
$829M
| $51.3M | 0.01% |
2,372,496
-1,975,411
| -45% | -$39.5M |
|
828
Luxfer Holdings
LXFR
$457M
| $51.1M | 0.01% |
3,424,061
+8,220
| +0.2% | +$127K |
|
829
Autoliv
ALV
$8.85B
| $51.1M | 0.01% |
663,211
-693,939
| -51% | -$48.6M |
|
|
BRS
830
DELISTED
Bristow Group, Inc.
BRS
| $51.1M | 0.01% |
776,235
+764,055
| +6,273% | +$51.6M |
|
831
Aflac
AFL
$60.5B
| $50.9M | 0.01% |
1,666,846
+32,020
| +2% | +$946K |
|
|
COBZ
832
DELISTED
CoBiz Financial,Inc
COBZ
| $50.9M | 0.01% |
3,875,297
-39,500
| -1% | -$473K |
|
833
Franklin Resources
BEN
$17.1B
| $50.4M | 0.01% |
909,909
-105,605
| -10% | -$5.83M |
|
834
Badger Meter
BMI
$3.91B
| $50.3M | 0.01% |
1,694,572
+81,352
| +5% | +$2.23M |
|
|
SNV
835
DELISTED
Synovus
SNV
| $50.2M | 0.01% |
1,854,427
+4,162
| +0.2% | +$105K |
|
836
RingCentral
RNG
$5.25B
| $50.1M | 0.01% |
3,361,174
-137,961
| -4% | -$1.73M |
|
837
WD-40
WDFC
$3.12B
| $50.1M | 0.01% |
589,288
+4,438
| +0.8% | +$338K |
|
838
Northrop Grumman
NOC
$82B
| $49.8M | 0.01% |
337,889
-2,690
| -0.8% | -$369K |
|
839
International Flavors & Fragrances
IFF
$21.4B
| $49.7M | 0.01% |
490,577
+130,740
| +36% | +$12.9M |
|
840
Angi Inc
ANGI
$176M
| $49.6M | 0.01% |
795,481
+135,377
| +21% | +$9.05M |
|
|
GTLS
841
DELISTED
Chart Industries
GTLS
| $49.1M | 0.01% |
1,435,588
+632,918
| +79% | +$26.4M |
|
842
Aaon
AAON
$7.03B
| $48.9M | 0.01% |
3,272,841
+32,100
| +1% | +$428K |
|
843
Piper Sandler
PIPR
$5.34B
| $48.6M | 0.01% |
3,348,880
-732,680
| -18% | -$10.1M |
|
844
Polaris
PII
$3.9B
| $48.5M | 0.01% |
320,959
+75,315
| +31% | +$11.3M |
|
845
Cummins
CMI
$87.8B
| $48.5M | 0.01% |
336,377
+610
| +0.2% | +$86.3K |
|
|
KS
846
DELISTED
KapStone Paper and Pack Corp.
KS
| $48.2M | 0.01% |
1,645,540
+256,985
| +19% | +$7.48M |
|
|
HIBB
847
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $48.2M | 0.01% |
995,585
-1,345,040
| -57% | -$62.4M |
|
848
Haemonetics
HAE
$4.16B
| $48.1M | 0.01% |
1,285,080
+269,900
| +27% | +$9.89M |
|
849
BJ's Restaurants
BJRI
$1.48B
| $47.9M | 0.01% |
954,053
-399,660
| -30% | -$17.5M |
|
|
SGEN
850
DELISTED
Seagen Inc. Common Stock
SGEN
| $47.8M | 0.01% |
1,487,354
-850,270
| -36% | -$29.6M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.